Empowered Patients: Redefining Healthcare

As published in the SV January 2025 Newsletter

In recent years, the healthcare landscape has experienced significant transformations, largely driven by technological advancements that empower patients to take a more active role in managing their health. The statistics reflect this shift:

Wearable Health Devices

• Market Growth: The global market for wearable medical devices was valued at approximately $24 billion in 2023 and is projected to reach $72.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.8%.

• Consumer Adoption: A survey revealed that 80% of consumers own at least one personal medical device, such as blood pressure monitors, electric toothbrushes, or fitness trackers. Notably, 28% of users have received alerts for potential health issues from these devices, and 84% found this data valuable.

  

Telemedicine

• Market Expansion: The medical devices market, encompassing telemedicine platforms, was valued at $810.4 billion in 2024 and is projected to reach $1.29 trillion by 2029, reflecting a CAGR of 9.8%.

Personalized Health Tools

• Digital Health Market: The global digital health market was valued at $240.85 billion in 2023 and is projected to reach approximately $1,635.11 billion by 2033, indicating substantial growth in personalized health tools and services.

  
  

Defender Leads Way in Empowering Patients  with Diabetic Foot Ulcers

Defender, a medical device company specializing in protecting at-risk feet and lower extremities, is transforming diabetic foot ulcer (DFU) care with its AI-powered disease management platform. The DFU Patient Platform supports patients through all stages, from wound healing to prevention, while enco

uraging active participation in their care. Defender has partnered with AlexiGen, Anderson Medical Supplies, and Sensoria to enhance patient support, solidifying its leadership in DFU care. Recognized as the "new standard of care," Foot Defender is utilized in over 10 clinical trials, including the NIH RO1 study, the DFU "smart boot" trial, and LifeNet Health initiatives.

These developments underscore a significant shift toward patient empowerment, with technology playing a pivotal role in enabling individuals to manage their health proactively and collaboratively.

Please contact Tony Coretto for more information or to arrange a meeting with Jason.